PureTech Health Free Cash Flow (FCF) History (PTCHF)

PureTech Health reported −$134.4M in free cash flow for fiscal 2024, a decrease of $28.4M from the previous fiscal year, with a free cash flow margin of −2783.35%.

View full PureTech Health company overview

PureTech Health free cash flow by year

PureTech Health annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20242024-12-31−$134.4M−$28.4M−2783.35%
20232023-12-31−$106.0M$75.0M−3182.79%
20222022-12-31−$181.0M−$17.1M−1158.71%
20212021-12-31−$163.8M−$26.8M−942.29%
20202020-12-31−$137.0M−$26.7M−1164.15%
20192019-12-31−$110.3M−$33.1M−1124.65%
20182018-12-31−$77.2M−371.90%

PureTech Health free cash flow growth trends

Over the last five reported fiscal years, free cash flow declined from −$110.3M to −$134.4M, a net decrease of $24.1M.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review PureTech Health filings at SEC.gov ↗